Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
- PMID: 32962148
- PMCID: PMC7565862
- DOI: 10.3390/vaccines8030544
Pneumocystis jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?
Abstract
COVID-19 might potentially give rise to a more severe infection in solid organ transplant recipients due to their chronic immunosuppression. These patients are at a higher risk of developing concurrent or secondary bacterial and fungal infections. Co-infections can increase systemic inflammation influencing the prognosis and the severity of the disease, and can in turn lead to an increased need of mechanical ventilation, antibiotic therapy and to a higher mortality. Here we describe, for the first time in Europe, a fatal case of co-infection between SARS-CoV-2 and Pneumocystis jirevocii in a kidney transplant recipient.
Keywords: COVID-19; immunosuppression; pneumonia.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Successful management of concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in kidney transplant recipients: a case series.BMC Pulm Med. 2023 Nov 21;23(1):458. doi: 10.1186/s12890-023-02764-2. BMC Pulm Med. 2023. PMID: 37990199 Free PMC article.
-
Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study.Virol J. 2022 Mar 4;19(1):35. doi: 10.1186/s12985-022-01763-9. Virol J. 2022. PMID: 35246169 Free PMC article.
-
Difference between SARS-CoV-2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients.Transpl Infect Dis. 2023 Feb;25(1):e13998. doi: 10.1111/tid.13998. Epub 2022 Dec 14. Transpl Infect Dis. 2023. PMID: 36477946 Free PMC article.
-
Risk of severe COVID in solid organ transplant recipient.Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):15-17. doi: 10.37201/req/s01.04.2023. Epub 2023 Nov 24. Rev Esp Quimioter. 2023. PMID: 37997864 Free PMC article. Review.
-
Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.Rom J Intern Med. 2021 Mar 5;59(1):10-42. doi: 10.2478/rjim-2020-0034. Print 2021 Mar 1. Rom J Intern Med. 2021. PMID: 33155999
Cited by
-
Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.Ann Clin Microbiol Antimicrob. 2021 Dec 15;20(1):83. doi: 10.1186/s12941-021-00489-w. Ann Clin Microbiol Antimicrob. 2021. PMID: 34911528 Free PMC article.
-
Detection of Pneumocystis jirovecii in Patients with Severe COVID-19: Diagnostic and Therapeutic Challenges.J Fungi (Basel). 2021 Jul 22;7(8):585. doi: 10.3390/jof7080585. J Fungi (Basel). 2021. PMID: 34436124 Free PMC article.
-
Invasive Fungal Infections Complicating COVID-19: A Narrative Review.J Fungi (Basel). 2021 Oct 29;7(11):921. doi: 10.3390/jof7110921. J Fungi (Basel). 2021. PMID: 34829210 Free PMC article. Review.
-
Pneumocystis pneumonia in COVID-19 patients: A comprehensive review.Heliyon. 2023 Feb;9(2):e13618. doi: 10.1016/j.heliyon.2023.e13618. Epub 2023 Feb 10. Heliyon. 2023. PMID: 36789388 Free PMC article.
-
Pneumocystis jirovecii Infections Among COVID-19 Patients: A Case Series and Literature Review.Open Forum Infect Dis. 2023 Jan 27;10(2):ofad043. doi: 10.1093/ofid/ofad043. eCollection 2023 Feb. Open Forum Infect Dis. 2023. PMID: 36817747 Free PMC article.
References
-
- ECDC . Coronavirus Disease 2019 (COVID-19) in the EU/EEA and the UK—Eleventh Update. ECDC; Stockholm, Sweden: 2020.
-
- De Wilde A.H., Snijder E.J., Kikkert M., van Hemert M.J. Host Factors in Coronavirus Replication. In: Tripp R.A., Tompkins S.M., editors. Roles of Host Gene and Non-Coding RNA Expression in Virus Infection. Springer International Publishing; Berlin/Heidelberg, Germany: 2018. pp. 1–42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous